This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reichert, M. Articles by Schneider, G. Search for Related Content PubMed PubMed Citation Articles by Reichert, M. Articles by Schneider, G.

Phosphoinositide-3-Kinase Signaling Controls S-Phase Kinase–Associated Protein 2 Transcription via E2F1 in Pancreatic Ductal Adenocarcinoma Cells

Department of Internal Medicine, Technical University of Munich, Munich, Germany

Requests for reprints: Günter Schneider, Technical University of Munich, Klinikum rechts der Isar, II. Department of Internal Medicine, Ismaninger Street 22, 81675 Munich, Germany. Phone: 49-8941402458; Fax: 49-8941404910; E-mail: guenter.schneider{at}lrz.tum.de.

The phosphoinositide-3-kinase (PI3K)/AKT signaling pathway controls fundamental processes of cancer cell biology like proliferation and cell survival. The PI3K/AKT pathway is activated in pancreatic ductal adenocarcinoma (PDAC) cells. The molecular mechanisms linking PI3K signaling to the cell cycle machinery in PDAC cells are not investigated in detail. Using the PI3K inhibitor Ly294002 as well as small interfering RNA targeting AKT1 expression, we show that PI3K controls the proliferation and G₁ phase progression of PDAC cells. Gene profiling revealed several important regulators of G₁-S phase progression controlled by PI3K signaling like p21^Cip1, S-phase kinase–associated protein 2 (SKP2), CDC25a, cyclin A, cyclin D2, CDK2, and cyclin E. We show that the F-box protein SKP2, an oncogene up-regulated in PDAC, is transcriptionally regulated by the PI3K/AKT1 pathway in PDAC cells. At the molecular level, the control of the SKP2 gene by PI3K is due to the regulation of E2F1 binding to the proximal SKP2 gene promoter. The complex and profound connection of PI3K/AKT1 signaling to the cell cycle qualifies this pathway as a suitable target for therapeutic intervention in PDAC. [Cancer Res 2007;67(9):4149–56]

This article has been cited by other articles:

				B. T. Hennessy, A.-M. Gonzalez-Angulo, K. Stemke-Hale, M. Z. Gilcrease, S. Krishnamurthy, J.-S. Lee, J. Fridlyand, A. Sahin, R. Agarwal, C. Joy, et al. Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics Cancer Res., May 15, 2009; 69(10): 4116 - 4124. [Abstract] [Full Text] [PDF]

				X.-C. Wang, Y.-P. Wu, B. Ye, D.-C. Lin, Y.-B. Feng, Z.-Q. Zhang, X. Xu, Y.-L. Han, Y. Cai, J.-T. Dong, et al. Suppression of Anoikis by SKP2 Amplification and Overexpression Promotes Metastasis of Esophageal Squamous Cell Carcinoma Mol. Cancer Res., January 1, 2009; 7(1): 12 - 22. [Abstract] [Full Text] [PDF]

				W.-J. Song, W. E. Schreiber, E. Zhong, F.-F. Liu, B. D. Kornfeld, F. E. Wondisford, and M. A. Hussain Exendin-4 Stimulation of Cyclin A2 in {beta}-Cell Proliferation Diabetes, September 1, 2008; 57(9): 2371 - 2381. [Abstract] [Full Text] [PDF]

				K. Nakamura, H. Sakaue, A. Nishizawa, Y. Matsuki, H. Gomi, E. Watanabe, R. Hiramatsua, M. Tamamori-Adachi, S. Kitajima, T. Noda, et al. PDK1 Regulates Cell Proliferation and Cell Cycle Progression through Control of Cyclin D1 and p27Kip1 Expression J. Biol. Chem., June 20, 2008; 283(25): 17702 - 17711. [Abstract] [Full Text] [PDF]